Please use this identifier to cite or link to this item: https://doi.org/10.1136/jmedgenet-2017-104752
Title: Intermediate C9orf72 alleles in neurological disorders: Does size really matter
Authors: Ng A.S.L. 
Tan E.-K. 
Issue Date: 2017
Publisher: BMJ Publishing Group
Citation: Ng A.S.L., Tan E.-K. (2017). Intermediate C9orf72 alleles in neurological disorders: Does size really matter. Journal of Medical Genetics 54 (9) : 591-597. ScholarBank@NUS Repository. https://doi.org/10.1136/jmedgenet-2017-104752
Abstract: C9orf72 repeat expansions is a major cause of familial frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) worldwide. Sizes of <20 hexanucleotide repeats are observed in controls, while up to thousands associate with disease. Intermediate C9orf72 repeat lengths, however, remain uncertain. We systematically reviewed the role of intermediate C9orf72 alleles in C9orf72-related neurological disorders. We identified 49 studies with adequate available data on normal or intermediate C9orf72 repeat length, involving subjects with FTD, ALS, Parkinson's disease (PD), atypical parkinsonism, Alzheimer's disease (AD) and other aetiologies. We found that, overall, normal or intermediate C9orf72 repeat lengths are not associated with higher disease risk across these disorders, but intermediate allele sizes appear to associate more frequently with neuropsychiatric phenotypes. Intermediate sizes were detected in subjects with personal or family history of FTD and/ or psychiatric illness, parkinsonism complicated by psychosis and rarely in psychiatric cohorts. Length of the hexanucleotide repeat may be influenced by ethnicity (with Asian controls displaying shorter normal repeat lengths compared with Caucasians) and underlying haplotype, with more patients and controls carrying the 'risk' haplotype rs3849942 displaying intermediate alleles. There is some evidence that intermediate alleles display increased methylation levels and affect normal transcriptional activity of the C9orf72 promoter, but the 'critical' repeat size required for initiation of neurodegeneration remains unknown and requires further study. In common neurological diseases, intermediate C9orf72 repeats do not influence disease risk but may associate with higher frequency of neuropsychiatric symptoms. This has important clinical relevance as intermediate carriers pose a challenge for genetic counselling. � Article author(s).
Source Title: Journal of Medical Genetics
URI: http://scholarbank.nus.edu.sg/handle/10635/148990
ISSN: 222593
DOI: 10.1136/jmedgenet-2017-104752
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

31
checked on May 13, 2022

WEB OF SCIENCETM
Citations

30
checked on Oct 6, 2021

Page view(s)

33
checked on May 12, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.